Displaying 3741 - 3760 of 4770
Commission Approves Petition for Proposed Divestiture from Agrium Inc.
FTC Announces Agenda for Petroleum Market Manipulation Rulemaking Workshop
Agrium Inc. and UAP Holding Corp ., In the Matter of
The Commission charged that Agrium, Inc.’s $2.65 billion proposed acquisition of UAP Holding Corporation would substantially lessen competition in the market for the retail sale of bulk fertilizer and, in some cases, related services by farm stores, in several local markets in Michigan and Maryland. The Commission’s order requires the divestiture of seven farm stores, five UAP stores in Michigan, and two Agrium locations on the eastern shore of Maryland.
Emerging Health Care Competition and Consumer Issues: Competitive Significance of Health Care Quality Information
FTC Announces Public Workshops for Next Year on Resale Price Maintenance
Hart-Scott-Rodino Premerger Notification Program Back to Basics Workshop
FTC Moves to Block CCSs Proposed Acquisition of Rival Newpark Environmental Services
Commission Approves Final Consent Order in Matter of Fresenius Medical Care AG & Co. KGaA/Daiichi Sankyo Company, Ltd.
Fresenius Medical Care AG & Co. KGaA, et al., In the Matter of
The Commission challenged Fresenius Medical Care’s proposed purchase of an exclusive sublicense for the manufacture and supply of the drug Venofer to US dialysis clinics from Daiichi Sankyo Company. Venofer is an intravenously administered iron sucrose preparation used primarily to treat iron-deficiency anemia in dialysis patients with chronic kidney disease. The agreement would have given Fresenius, the largest operator of dialysis clinics in the country, the ability to artificially inflate its internal costs for Venofer, and effectively increase Medicare reimbursement payments for all buyers of the drug. In order to settle these concerns about anticompetitive self-dealing, the Commission issued a consent order restricting Fresenius from reporting internally inflated Venofer prices by mandating that the current market price for the drug be used in reporting the average selling price to Medicare.
Section 5 of the FTC Act as a Competition Statute
Commission Issues "Excess Consideration" Order in Matter of Rambus, Inc.; FTC Approves Modified Final Consent Order in Matter of Pernod Ricard/V&S Vin & Sprit
Pernod Ricard S.A., In the Matter of
The Commission challenged Pernod Ricard SA’s proposed $9 billion acquisition of V&S Vin & Spirit as harmful to competition among suppliers of “super-premium” vodka. The proposed deal would have merged the two leading brands, Absolut and Stolichnaya, and allowed Pernod to raise prices profitably on both brands. Additionally, the complaint alleges that the markets for cognac, domestic cordials, coffee liqueur, and popular gin would be subject to anticompetitive effects because sensitive pricing and promotion information for Beam Global Brands, a competitor in these product markets, would be available to Pernod after the acquisition as a result of Beam’s joint venture with V&S. The Commission settled the charges by requiring Pernod to divest its distribution interests in Stolichnaya Vodka, and to erect a firewall to prevent the sharing of any competitively sensitive information from Beam Global Brands with Pernod employees.
Dicks Sporting Goods Settles FTC Charges of Illegal Market Allocation
FTC Announces Agenda for Section 5 Public Workshop on October 17, 2008
FTC Intervenes in Hexions Proposed Acquisition of Huntsman Corp.
Commission Approves Final Consent Order in Matter of Negotiated Data Solutions, LLC
Displaying 3741 - 3760 of 4770